Complex PCI – Planning and guidance of complex percutaneous coronary interventions

Prof Javier Escaned is Head of Interventional Cardiology Section at Hospital Clinico San Carlos (Madrid, Spain). He trained as a cardiologist the United Kingdom before moving to the Thoraxcenter / Rotterdam (The Netherlands), where he obtained his PhD degree in 1994. With over 30 years of experience as interventionalist, he regularly serves as live case operator and educationalist in global events. He is author of over 500 PubMed indexed scientific articles (h-index 74) on topics that include complex PCI in multivessel disease, left main and chronic total occlusions. His track record in coronary physiology includes being investigator on pivotal FFR trials like DEFER (1998), collaborator with Justin Davies in the validation and clinical implementation of iFR (since 2010), and developer of new methods for the assessment of microvascular and non-obstructive coronary disease. Editorial work includes two large textbooks (“Coronary Stenosis. Imaging, Structure and Physiology” and “Physiological Assessment of Coronary Stenoses and the Microcirculation) and editorial board positions in scientific journals. Board positions in scientific societies include EuroPCR, EAPCI, EuroCTO and the ESC Working Group of Coronary Pathophysiology and Microcirculation. Additional interest incllude music and phylosophy. He is a recipient of the ESC Silver Medal and the 2022 ESC Andreas Gruentzig Award.

Dr Justin Davies is founder and CEO of Wondr Medical, inventor of iFR, and clinical academic and consultant interventional cardiologist at the National Heart and Lung Institute, Imperial College London.

Angela McInerney is an Interventional Cardiologist at University Hospital Galway, Ireland. Following completion of her basic cardiology training in Ireland she was awarded the Brian McGovern Travelling Fellowship grant from the Irish Board for Cardiology Training in 2018 which allowed her to start her interventional fellowship in Hospital Clínico San Carlos, Madrid, Spain. Following two years of coronary training including complex PCI, she was awarded an European Society of Cardiology Fellowship Training Grant and completed a further year of structural intervention also in Clínico San Carlos, Madrid. Her specialist interests are in intracoronary imaging, intracoronary physiology, calcium modification techniques and complex PCI. She has been keenly involved in various research projects pertaining to intracoronary physiology and intravascular imaging having authored and co-authored a number of research articles as well as review articles and book chapters on these topics. During her fellowship she also regularly partook in the preparation and delivery of educational courses in Clínico San Carlos and values the educational aspect of her role as a Consultant Interventional Cardiologist.

Carlo Di Mario is Professor of Cardiology at the University of Florence and Director of the Structural 
Interventional Cardiology Division of the University Hospital Careggi, Florence, Italy. Previous posts included 15 years as Professor of Clinical Cardiology at Imperial College of Sciences, Medicine & Technology, London and Consultant Cardiologist at the Royal Brompton Hospital. Despite his teaching, research and administrative commitments, he maintains an active clinical involvement performing more than 100 PCI per year with special interest in the treatment of calcified lesions, chronic total occlusions, bifurcations, and diffuse disease. He is a regular TAVI operator and certified implanter for the Medtronic Evolut R and Edwards Sapien 3 transcatheter aortic valves. He participated in more than 160 MitraClip implantations in London and Florence and has recently started direct annuloplasty with the CardioBand. Professor Di Mario pioneered the use of intracoronary Doppler, pressure measurement, intravascular ultrasound, optical coherence tomography, and near infrared spectroscopy. He was PI of the OPTICUS trial, failing to demonstrate superiority of IVUS guided stenting, and of the Lipid Rich Plaque study, due to report at TCT 2018. He was Principal Investigator of the DESTINI trial, using Doppler CRF to identify lesions in need of stenting, and of the CARESS in AMI trial, a large multicentre trial showing that patients who receive fibrinolytic therapy for ST-elevation myocardial infarction benefit from early angioplasty. This trial and a subsequent meta-analysis have led to a change in the European Society of Cardiology and AHA/ACC Guidelines for treatment of STEMI patients. He cooperated with Dr Davies to the validation of iFR to assess lesion severity and discriminate the contribution of individual lesions, and with Dr Lyon in the intracoronary delivery of SERCA-2 genes via adenoviral vectors in the CUPID2 trial.

Dr. Dejan Milasinovic is an interventional cardiologist at the Department of Cardiology, Clinical Center of Serbia. He is also an Assistant Professor at Faculty of Medicine, University of Belgrade. His main research interests focus in the fields of the invasive treatment of acute coronary syndromes and complex coronary interventions, with an emphasis on bifurcation PCI and intracoronary guidance. In 2016, Dr. Milasinovic received the EuroPCR 2016 Best Abstract award, for a work on the timing of invasive coronary intervention in patients with non-ST-segment elevation myocardial infarction. He is a member of European Association of Percutaneous Cardiovascular Interventions (EAPCI) and has served as program committee member of the annual EuroPCR conference. Dr. Milasinovic also serves on the editorial boards of EuroIntervention (editorial consultant) and PCRonline, and is the Cahir of the Young EAPCI/PCR Journal Club at www.pcronline.com.

Dr Justin Davies is founder and CEO of Wondr Medical, inventor of iFR, and clinical academic and consultant interventional cardiologist at the National Heart and Lung Institute, Imperial College London.

Dr Marco Lombardi is an interventional cardiology fellow at the Hospital Clinico San Carlos/Complutense University (Madrid, Spain) from the Catholic University of the Sacred Heart (Rome, Italy). He obtained his medical degree at the Campus Bio-Medico University in 2018 (Rome, Italy), and he trained as a research fellow at the VCU Pauley Heart Center (Richmond, USA) before starting his PhD degree that he is completing at the University of Genoa (Genoa, Italy).

Sa’ar Minha MD is a professor of cardiology at Tel-Aviv University, Israel, and the director of interventional cardiology at Shamir Medical Center, Be’er Yaakov in Israel- one of the largest government-owned hospitals in the country. He also serves as the secretary of the interventional cardiology working group under the Israel Heart Society. Prof. Minha earned his MD degree from Tel-Aviv University in Israel and completed an internal medicine residency and cardiology fellowship at Shamir Medical Center. His interventional cardiology fellowship was completed in 2014 at the Washington Hospital Center, affiliated with Georgetown University, Washington DC under Prof. Ron Waksman, Prof. Gus Pichard, and Prof. Lowell Satler. Prof Minha is an active speaker and an invited faculty for major international cardiology conferences and the co-author of over 110 original research publications. His main interests are complex coronary interventions combining physiology and imaging for optimizing results and outcomes, interventions for pulmonary embolism, renal denervation for treating hypertension, and interventions under mechanical circulatory support.

Dr Tim Schäufele is an interventional cardiologist with special interest in CTOs, coronary physiology and calcified lesions. He is owner of Kardiologie-Innenstad Bern private practice and Interventional Cardiologist at Lindenhofspital Bern. Prior to this, he served as Head of Cathlab and Interventional Cardiology at Robert-Bosch-Krankenhaus Stuttgart, after serving as a Research Fellow in Cardiac Magnetic Imaging at the Department of Cardiology University Heidelberg. Dr Schäufele is a Co-Founding Member of Transradial Workingroup German Cardiac Society, a Board Member of the Interventional Working Group of the German Cardiac Society, and a Full Member EuroCTO Club.

Dr Adrián Jerónimo is an Interventional Cardiology fellow at Hospital Clínico San Carlos in Madrid (Spain). He studied Medicine at Universidad Complutense de Madrid and completed his General Cardiology training at Hospital Clínico San Carlos. He has collaborated in several research projects, including the AID ANGIO study, in which he plays a principal role. His main areas of interest are complex PCI, coronary physiology and intravascular imaging, being part of the CTO programme at Hospital Clínico San Carlos. In addition, he will be finishing his PhD in infective endocarditis and TAVI by the end of 2024.

Angela McInerney is an Interventional Cardiologist at University Hospital Galway, Ireland. Following completion of her basic cardiology training in Ireland she was awarded the Brian McGovern Travelling Fellowship grant from the Irish Board for Cardiology Training in 2018 which allowed her to start her interventional fellowship in Hospital Clínico San Carlos, Madrid, Spain. Following two years of coronary training including complex PCI, she was awarded an European Society of Cardiology Fellowship Training Grant and completed a further year of structural intervention also in Clínico San Carlos, Madrid. Her specialist interests are in intracoronary imaging, intracoronary physiology, calcium modification techniques and complex PCI. She has been keenly involved in various research projects pertaining to intracoronary physiology and intravascular imaging having authored and co-authored a number of research articles as well as review articles and book chapters on these topics. During her fellowship she also regularly partook in the preparation and delivery of educational courses in Clínico San Carlos and values the educational aspect of her role as a Consultant Interventional Cardiologist.

Dr. Dejan Milasinovic is an interventional cardiologist at the Department of Cardiology, Clinical Center of Serbia. He is also an Assistant Professor at Faculty of Medicine, University of Belgrade. His main research interests focus in the fields of the invasive treatment of acute coronary syndromes and complex coronary interventions, with an emphasis on bifurcation PCI and intracoronary guidance. In 2016, Dr. Milasinovic received the EuroPCR 2016 Best Abstract award, for a work on the timing of invasive coronary intervention in patients with non-ST-segment elevation myocardial infarction. He is a member of European Association of Percutaneous Cardiovascular Interventions (EAPCI) and has served as program committee member of the annual EuroPCR conference. Dr. Milasinovic also serves on the editorial boards of EuroIntervention (editorial consultant) and PCRonline, and is the Cahir of the Young EAPCI/PCR Journal Club at www.pcronline.com.

Prof Javier Escaned is Head of Interventional Cardiology Section at Hospital Clinico San Carlos (Madrid, Spain). He trained as a cardiologist the United Kingdom before moving to the Thoraxcenter / Rotterdam (The Netherlands), where he obtained his PhD degree in 1994. With over 30 years of experience as interventionalist, he regularly serves as live case operator and educationalist in global events. He is author of over 500 PubMed indexed scientific articles (h-index 74) on topics that include complex PCI in multivessel disease, left main and chronic total occlusions. His track record in coronary physiology includes being investigator on pivotal FFR trials like DEFER (1998), collaborator with Justin Davies in the validation and clinical implementation of iFR (since 2010), and developer of new methods for the assessment of microvascular and non-obstructive coronary disease. Editorial work includes two large textbooks (“Coronary Stenosis. Imaging, Structure and Physiology” and “Physiological Assessment of Coronary Stenoses and the Microcirculation) and editorial board positions in scientific journals. Board positions in scientific societies include EuroPCR, EAPCI, EuroCTO and the ESC Working Group of Coronary Pathophysiology and Microcirculation. Additional interest incllude music and phylosophy. He is a recipient of the ESC Silver Medal and the 2022 ESC Andreas Gruentzig Award.

Dr Justin Davies is founder and CEO of Wondr Medical, inventor of iFR, and clinical academic and consultant interventional cardiologist at the National Heart and Lung Institute, Imperial College London.

Dr Marco Lombardi is an interventional cardiology fellow at the Hospital Clinico San Carlos/Complutense University (Madrid, Spain) from the Catholic University of the Sacred Heart (Rome, Italy). He obtained his medical degree at the Campus Bio-Medico University in 2018 (Rome, Italy), and he trained as a research fellow at the VCU Pauley Heart Center (Richmond, USA) before starting his PhD degree that he is completing at the University of Genoa (Genoa, Italy).

Dr Nieves Gonzalo is Consultant Interventional Cardiologist at the Interventional Cardiology Department at Clinico San Carlos University Hospital in Madrid. She obtained her Specialist Certification in Cardiology after training at Clinico San Carlos University Hospital in Madrid. Subsequently, she underwent a research fellowship at Thoraxcenter, Erasmus University Rotterdam (The Netherlands) under the supervision of Professor Patrick Serruys, focused mainly in intracoronary imaging and bioabsorbable stents. In 2010 she obtained her PhD with the thesis “Optical coherence tomography for the assessment of coronary atherosclerosis and vessel response after stent implantation”. Her track record includes over 170 articles indexed in PubMed, as well as book chapters in Interventional Cardiology textbooks. Recent research projects as principal investigator includes a study about the assessment of neoatherosclerosis and its clinical impact in patients with restenosis (RIBS IV and V OCT substudy) and research regarding vessel injury and healing evaluation with different stent platforms evaluated with OCT (VISTA study). Dr Gonzalo is a dedicated educationalist with involvement in many areas of complex PCI, serving currently as Deputy Editor for Eurointervention and Committee Member of EuroPCR.

Sa’ar Minha MD is a professor of cardiology at Tel-Aviv University, Israel, and the director of interventional cardiology at Shamir Medical Center, Be’er Yaakov in Israel- one of the largest government-owned hospitals in the country. He also serves as the secretary of the interventional cardiology working group under the Israel Heart Society. Prof. Minha earned his MD degree from Tel-Aviv University in Israel and completed an internal medicine residency and cardiology fellowship at Shamir Medical Center. His interventional cardiology fellowship was completed in 2014 at the Washington Hospital Center, affiliated with Georgetown University, Washington DC under Prof. Ron Waksman, Prof. Gus Pichard, and Prof. Lowell Satler. Prof Minha is an active speaker and an invited faculty for major international cardiology conferences and the co-author of over 110 original research publications. His main interests are complex coronary interventions combining physiology and imaging for optimizing results and outcomes, interventions for pulmonary embolism, renal denervation for treating hypertension, and interventions under mechanical circulatory support.

Dr Tim Schäufele is an interventional cardiologist with special interest in CTOs, coronary physiology and calcified lesions. He is owner of Kardiologie-Innenstad Bern private practice and Interventional Cardiologist at Lindenhofspital Bern. Prior to this, he served as Head of Cathlab and Interventional Cardiology at Robert-Bosch-Krankenhaus Stuttgart, after serving as a Research Fellow in Cardiac Magnetic Imaging at the Department of Cardiology University Heidelberg. Dr Schäufele is a Co-Founding Member of Transradial Workingroup German Cardiac Society, a Board Member of the Interventional Working Group of the German Cardiac Society, and a Full Member EuroCTO Club.

Angela McInerney is an Interventional Cardiologist at University Hospital Galway, Ireland. Following completion of her basic cardiology training in Ireland she was awarded the Brian McGovern Travelling Fellowship grant from the Irish Board for Cardiology Training in 2018 which allowed her to start her interventional fellowship in Hospital Clínico San Carlos, Madrid, Spain. Following two years of coronary training including complex PCI, she was awarded an European Society of Cardiology Fellowship Training Grant and completed a further year of structural intervention also in Clínico San Carlos, Madrid. Her specialist interests are in intracoronary imaging, intracoronary physiology, calcium modification techniques and complex PCI. She has been keenly involved in various research projects pertaining to intracoronary physiology and intravascular imaging having authored and co-authored a number of research articles as well as review articles and book chapters on these topics. During her fellowship she also regularly partook in the preparation and delivery of educational courses in Clínico San Carlos and values the educational aspect of her role as a Consultant Interventional Cardiologist.

Dr. Dejan Milasinovic is an interventional cardiologist at the Department of Cardiology, Clinical Center of Serbia. He is also an Assistant Professor at Faculty of Medicine, University of Belgrade. His main research interests focus in the fields of the invasive treatment of acute coronary syndromes and complex coronary interventions, with an emphasis on bifurcation PCI and intracoronary guidance. In 2016, Dr. Milasinovic received the EuroPCR 2016 Best Abstract award, for a work on the timing of invasive coronary intervention in patients with non-ST-segment elevation myocardial infarction. He is a member of European Association of Percutaneous Cardiovascular Interventions (EAPCI) and has served as program committee member of the annual EuroPCR conference. Dr. Milasinovic also serves on the editorial boards of EuroIntervention (editorial consultant) and PCRonline, and is the Cahir of the Young EAPCI/PCR Journal Club at www.pcronline.com.

Dr Justin Davies is founder and CEO of Wondr Medical, inventor of iFR, and clinical academic and consultant interventional cardiologist at the National Heart and Lung Institute, Imperial College London.

Prof Maciej Lesiak is Head of the 1st Department of Cardiology in Poznan Medical University and a cardiology consultant in Greater Poland province. He obtained medical diploma at the Medical Academy in Poznan (currently the Medical University) and at this university he gained further academic degrees and promotions. He received his doctorate in 1995 defending the work entitled Structure of the sinus node in healthy persons and patients with supraventricular rhythm disorders. His specialization is internal diseases and cardiology.In 2001, he was a member of the team of Poznan cardiologists who prepared the first program for the invasive treatment of acute myocardial infarction in Greater Poland province. In 2007, he became Associate Professor based on the assessment of scientific achievements and dissertation titled “Primary coronary angioplasty in the treatment of acute phase of myocardial infarction. Early and long-term observation of 988 consecutive patients treated as part of the Greater Poland Province Program”. Prof Lesiak became a Professor of medical sciences in 2016. Prof Lesiak has been a member of the Board of the Working Group for Invasive Cardiology of The Polish Cardiac Society since 2001, and its president in years 2009 - 2011; Member of European Society of Cardiology since 2002, and a EuroPCR Program Committee Member since 2009. He is also an associate editor of the Polish Heart Journal. Prof Lesiak has published over 140 original publications in magazines such as European Heart Journal, JACC, JACC Cardiovascular Interventions, American Heart Journal, etc.

Dr Roberto Spina is an Interventional Cardiologist trained in Australia and the USA and is a Fellow of the Royal Australasian College of Physicians. He specialises in transcatheter structural heart interventions, having undertaken a Structural Heart Intervention Advanced Fellowship at the New York Presbyterian Hospital/Columbia University Medical Center in New York, USA, and complex coronary intervention. He strongly believes in the routine use of intravascular imaging in performing percutaneous coronary intervention.

Dr Tim Schäufele is an interventional cardiologist with special interest in CTOs, coronary physiology and calcified lesions. He is owner of Kardiologie-Innenstad Bern private practice and Interventional Cardiologist at Lindenhofspital Bern. Prior to this, he served as Head of Cathlab and Interventional Cardiology at Robert-Bosch-Krankenhaus Stuttgart, after serving as a Research Fellow in Cardiac Magnetic Imaging at the Department of Cardiology University Heidelberg. Dr Schäufele is a Co-Founding Member of Transradial Workingroup German Cardiac Society, a Board Member of the Interventional Working Group of the German Cardiac Society, and a Full Member EuroCTO Club.

Dr Asad Shabbir is an Interventional Cardiology Fellow at Hospital Clinico San Carlos, Madrid, Spain. He is also an Honorary Clinical Research Fellow at the William Harvey Research Institute, Queen Mary University of London. Asad undertook his cardiology training in Oxford, before undertaking a PhD in translational basic science at Barts and The London School of Medicine and Dentistry. Asad has an interest in coronary and structural intervention, and basic science.

Dr. Dejan Milasinovic is an interventional cardiologist at the Department of Cardiology, Clinical Center of Serbia. He is also an Assistant Professor at Faculty of Medicine, University of Belgrade. His main research interests focus in the fields of the invasive treatment of acute coronary syndromes and complex coronary interventions, with an emphasis on bifurcation PCI and intracoronary guidance. In 2016, Dr. Milasinovic received the EuroPCR 2016 Best Abstract award, for a work on the timing of invasive coronary intervention in patients with non-ST-segment elevation myocardial infarction. He is a member of European Association of Percutaneous Cardiovascular Interventions (EAPCI) and has served as program committee member of the annual EuroPCR conference. Dr. Milasinovic also serves on the editorial boards of EuroIntervention (editorial consultant) and PCRonline, and is the Cahir of the Young EAPCI/PCR Journal Club at www.pcronline.com.

Prof Javier Escaned is Head of Interventional Cardiology Section at Hospital Clinico San Carlos (Madrid, Spain). He trained as a cardiologist the United Kingdom before moving to the Thoraxcenter / Rotterdam (The Netherlands), where he obtained his PhD degree in 1994. With over 30 years of experience as interventionalist, he regularly serves as live case operator and educationalist in global events. He is author of over 500 PubMed indexed scientific articles (h-index 74) on topics that include complex PCI in multivessel disease, left main and chronic total occlusions. His track record in coronary physiology includes being investigator on pivotal FFR trials like DEFER (1998), collaborator with Justin Davies in the validation and clinical implementation of iFR (since 2010), and developer of new methods for the assessment of microvascular and non-obstructive coronary disease. Editorial work includes two large textbooks (“Coronary Stenosis. Imaging, Structure and Physiology” and “Physiological Assessment of Coronary Stenoses and the Microcirculation) and editorial board positions in scientific journals. Board positions in scientific societies include EuroPCR, EAPCI, EuroCTO and the ESC Working Group of Coronary Pathophysiology and Microcirculation. Additional interest incllude music and phylosophy. He is a recipient of the ESC Silver Medal and the 2022 ESC Andreas Gruentzig Award.

Dr Justin Davies is founder and CEO of Wondr Medical, inventor of iFR, and clinical academic and consultant interventional cardiologist at the National Heart and Lung Institute, Imperial College London.

Dr. Pablo Salinas is Interventional Cardiologist at Hospital Clínico San Carlos in Madrid, Spain. He studied Medicine at Universidad Complutense in Madrid, Spain and was trained in Cardiology and Interventional Cardiology at Hospital La Paz in Madrid, Spain. In 2015 he obtained his PhD degree (cum laude) at the Universidad Autonoma in Madrid. He has developed his professional career in the field of interventional cardiology for over 10 years, and is a skilled operator in complex coronary intervention, chronic occlusions, and stroke prevention therapies such as foramen ovale closure and appendage closure, with regular participation in educational events and live cases. During his research career he has 80+ PubMed indexed publications and is currently the PI of three multicenter studies SUGAR Trial (NCT03321032), REVASEC Registry (NCT03349385), and TROMPA Registry. Also he has been researcher in several investigator initiated, competitive funding research (PI16 / 00840, PIE16 / 00043, PI15 / 00742).

Dr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust in London, UK. Dr Al-Lamee’s research interests are complex coronary intervention, coronary physiology and invasive intravascular assessment. She designed, conducted and led the ORBITA trial and is the lead author of the primary publication in The Lancet. At Imperial College, she is actively involved in the development and recruitment for a number of multi-centre clinical trials. Dr Al- Lamee has over 40 peer-reviewed publications and has presented at international Cardiology conferences worldwide throughout her clinical career. She studied at the University of Oxford and University College London. She went onto complete her training as a junior doctor on the Barts and the London Medical rotation before being appointed as a Specialist Registrar on the North West London Cardiology rotation in 2006. Dr Al-Lamee has twelve years of Cardiology experience and completed three years of Interventional Fellowship training at Hammersmith Hospital in London. She also spent a year training as an Interventional Fellow under the supervision of Professor Antonio Colombo in Milan. She completed specialist training in Cardiology in 2013.

Vasilis Panoulas is a medical doctor.

Dr Adrián Jerónimo is an Interventional Cardiology fellow at Hospital Clínico San Carlos in Madrid (Spain). He studied Medicine at Universidad Complutense de Madrid and completed his General Cardiology training at Hospital Clínico San Carlos. He has collaborated in several research projects, including the AID ANGIO study, in which he plays a principal role. His main areas of interest are complex PCI, coronary physiology and intravascular imaging, being part of the CTO programme at Hospital Clínico San Carlos. In addition, he will be finishing his PhD in infective endocarditis and TAVI by the end of 2024.

Dr Breda Hennessey graduated from the Third Faculty of Medicine in Charles University in Prague. Following this, she returned to Ireland to complete her general medical and higher specialist cardiology training. In 2019, she was awarded the Brian McGovern Scholarship by the Irish Cardiac Society, and this allowed her to commence her subspecialty training in Interventional Cardiology at Hospital Clínico San Carlos in Madrid. She completed a two-year coronary interventional fellowship, with a focus on intracoronary imaging, invasive physiology and ultra-low dose contrast intervention. Following completion of her coronary training, she undertook a further fellowship in structural intervention, also at Hospital Clínico San Carlos. In addition to her clinical work, she has been involved in various research projects pertaining to ultra-low dose contrast PCI, investigating the impact of new technologies in reducing contrast burden in complex PCI . She has authored and co-authored a number of research articles, book chapters and has contributed to the European association of Percutaneous Cardiovascular Interventions textbook. During her time at Hospital Clinico San Carlos, she completed a Masters in Interventional Cardiology and is currently undertaking a PHD at the Complutense University of Madrid with a focus in ultra-low dose contrast PCI. Throughout her fellowship, she regularly took part in the preparation and delivery of educational courses, both at Hospital Clinico San Carlos and in collaboration with other tertiary referral centres and international cardiology societies in Spain, the UK and the UAE.

Prof Javier Escaned is Head of Interventional Cardiology Section at Hospital Clinico San Carlos (Madrid, Spain). He trained as a cardiologist the United Kingdom before moving to the Thoraxcenter / Rotterdam (The Netherlands), where he obtained his PhD degree in 1994. With over 30 years of experience as interventionalist, he regularly serves as live case operator and educationalist in global events. He is author of over 500 PubMed indexed scientific articles (h-index 74) on topics that include complex PCI in multivessel disease, left main and chronic total occlusions. His track record in coronary physiology includes being investigator on pivotal FFR trials like DEFER (1998), collaborator with Justin Davies in the validation and clinical implementation of iFR (since 2010), and developer of new methods for the assessment of microvascular and non-obstructive coronary disease. Editorial work includes two large textbooks (“Coronary Stenosis. Imaging, Structure and Physiology” and “Physiological Assessment of Coronary Stenoses and the Microcirculation) and editorial board positions in scientific journals. Board positions in scientific societies include EuroPCR, EAPCI, EuroCTO and the ESC Working Group of Coronary Pathophysiology and Microcirculation. Additional interest incllude music and phylosophy. He is a recipient of the ESC Silver Medal and the 2022 ESC Andreas Gruentzig Award.

Dr Marco Lombardi is an interventional cardiology fellow at the Hospital Clinico San Carlos/Complutense University (Madrid, Spain) from the Catholic University of the Sacred Heart (Rome, Italy). He obtained his medical degree at the Campus Bio-Medico University in 2018 (Rome, Italy), and he trained as a research fellow at the VCU Pauley Heart Center (Richmond, USA) before starting his PhD degree that he is completing at the University of Genoa (Genoa, Italy).

Sa’ar Minha MD is a professor of cardiology at Tel-Aviv University, Israel, and the director of interventional cardiology at Shamir Medical Center, Be’er Yaakov in Israel- one of the largest government-owned hospitals in the country. He also serves as the secretary of the interventional cardiology working group under the Israel Heart Society. Prof. Minha earned his MD degree from Tel-Aviv University in Israel and completed an internal medicine residency and cardiology fellowship at Shamir Medical Center. His interventional cardiology fellowship was completed in 2014 at the Washington Hospital Center, affiliated with Georgetown University, Washington DC under Prof. Ron Waksman, Prof. Gus Pichard, and Prof. Lowell Satler. Prof Minha is an active speaker and an invited faculty for major international cardiology conferences and the co-author of over 110 original research publications. His main interests are complex coronary interventions combining physiology and imaging for optimizing results and outcomes, interventions for pulmonary embolism, renal denervation for treating hypertension, and interventions under mechanical circulatory support.

Prof Javier Escaned is Head of Interventional Cardiology Section at Hospital Clinico San Carlos (Madrid, Spain). He trained as a cardiologist the United Kingdom before moving to the Thoraxcenter / Rotterdam (The Netherlands), where he obtained his PhD degree in 1994. With over 30 years of experience as interventionalist, he regularly serves as live case operator and educationalist in global events. He is author of over 500 PubMed indexed scientific articles (h-index 74) on topics that include complex PCI in multivessel disease, left main and chronic total occlusions. His track record in coronary physiology includes being investigator on pivotal FFR trials like DEFER (1998), collaborator with Justin Davies in the validation and clinical implementation of iFR (since 2010), and developer of new methods for the assessment of microvascular and non-obstructive coronary disease. Editorial work includes two large textbooks (“Coronary Stenosis. Imaging, Structure and Physiology” and “Physiological Assessment of Coronary Stenoses and the Microcirculation) and editorial board positions in scientific journals. Board positions in scientific societies include EuroPCR, EAPCI, EuroCTO and the ESC Working Group of Coronary Pathophysiology and Microcirculation. Additional interest incllude music and phylosophy. He is a recipient of the ESC Silver Medal and the 2022 ESC Andreas Gruentzig Award.